Atlas Trials

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Clinical trial NCT04226456 · TERMINATED

Trial details

NCT number
NCT04226456
Sponsor
Centre Hospitalier Universitaire Saint Pierre
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicityTinnitus
Start date
2021-07-10
Primary completion
2023-05-03
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.